Corpus Intelligence IC Memo — SSM HEALTH ST. JOSEPH HOSPITAL - LSL 2026-04-26 06:38 UTC
IC Memo — SSM HEALTH ST. JOSEPH HOSPITAL - LSL
Investment Committee Memorandum | MO | 179 beds | Grade C | EBITDA uplift $15.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSM HEALTH ST. JOSEPH HOSPITAL - LSL

CCN 260200 | ST. CHARLES, MO | 179 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SSM HEALTH ST. JOSEPH HOSPITAL - LSL is a 179-bed suburban community hospital in ST. CHARLES, MO with $208.4M in net patient revenue and a 1.5% operating margin. The hospital serves a payer mix of 24.8% Medicare, 7.0% Medicaid, and 68.2% commercial.

Thesis: Undervalued. Our ML models identify $15.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.5% to 8.9% (+736bps).

Net Revenue HCRIS$208.4M
Current EBITDA COMPUTED$3.2M
Operating Margin COMPUTED1.5%
Occupancy HCRIS74.5%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS26.3%
Distress Probability ML43.0%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
41
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of 1.5% places it above the state median. Among 41 size-comparable peers (90-358 beds), the median margin is -3.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (90-358), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSM HEALTH ST. JOSEPH HOSPITAL (Target)MO179$208.4M1.5%
CHILDRENS MERCY HOSPITALMO328$1.44B30.5%
SSM SAINT LOUIS UNIVERSITY HOSMO317$772.2M-6.4%
HEARTLAND REGIONAL MEDICAL CENMO352$676.9M-6.2%
SAINT FRANCIS MEDICAL CENTERMO282$556.6M-1.3%
UNIVERSITY HEALTH TRUMAN MED CMO258$540.8M-13.5%
AMEND #2 RESEARCH MEDICAL CENTMO337$487.0M-5.2%
AMEND 1 CENTERPOINT MEDICAL CEMO265$378.8M19.2%
BOONE HOSPITAL CENTERMO278$346.5M-22.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $15.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.4M+210bp18mo
Cost to Collect4.5%2.5%$4.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.5M+122bp9mo
Clean Claim Rate88.0%96.0%$133K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.4M
Cost to Collect
$4.2M
Denial Rate Reduction
$4.1M
A/R Days Reduction
$2.5M
Clean Claim Rate
$133K
Total EBITDA Uplift$15.3M
Current EBITDA$3.2M
+ RCM Uplift+$15.3M
Pro Forma EBITDA$18.6M
Current Margin1.5%
Pro Forma Margin8.9%
WC Released (1x)$8.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$5.0M$174.6M35.26x103.9%
Base (11x exit)10.0x11.0x$5.0M$193.7M39.12x108.2%
Bull Case9.0x11.0x$4.5M$245.9M55.18x123.0%
Bull (12x exit)9.0x12.0x$4.5M$269.6M60.49x127.2%
Bear Case11.0x10.0x$5.4M$96.3M17.68x77.6%
Bear (11x exit)11.0x11.0x$5.4M$107.7M19.78x81.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 90-358 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-15.2% / P50=-3.2% / P75=6.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.